The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Aardvark Therapeutics, Inc. announced progress in its Phase 3 HERO trial for ARD-101, aimed at treating hyperphagia associated with Prader-Willi Syndrome, with data expected in early 2026. The company ...
Aardvark Therapeutics has seen its share price halve in value after the company paused a phase 3 study of its lead metabolic asset over heart-related data. The San Diego-based biotech has been ...
SAN DIEGO - Aardvark Therapeutics, Inc. (NASDAQ:AARD), a biopharmaceutical company engaged in developing treatments for metabolic diseases with a market capitalization of $214.57 million, announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results